What is Devyser?
Devyser is a pioneering provider of diagnostic DNA test kits, catering to laboratories worldwide with solutions designed for speed, precision, and ease of use. Their comprehensive product portfolio spans critical diagnostic areas including oncology, hematology, reproductive health, and cystic fibrosis. By empowering healthcare providers with advanced genetic testing capabilities, Devyser is instrumental in enhancing patient outcomes through more accurate and timely diagnoses.
How much funding has Devyser raised?
Devyser has raised a total of $900K across 1 funding round:
Grant
$900K
Grant (2021): $900K, investors not publicly disclosed
What's next for Devyser?
The recent major strategic investment signals a new phase of growth and development for Devyser. This capital infusion is expected to fuel further innovation in their diagnostic test kit offerings, potentially expanding their reach into new therapeutic areas or geographical markets. The company's focus on personalized medicine positions it for continued expansion as the demand for advanced genetic diagnostics intensifies globally.
See full Devyser company page
